Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(20S)-19,20,22,23-tetrahydro-19-oxo-5H,21H-18,20-ethano-12,14-etheno-6,10-methenobenz[d]imidazo[4,3-l][1,6,9,13]oxatriazacyclonoadedecosine-9-carbonitrile
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Not Available / Not Established For Clinical Use.
01
Overview
This compound is a synthetic small molecule with the chemical formula C27H27N5O2 and a molecular weight of approximately 453.54 g/mol.[1] It is known as U66 in structural biology databases and has been used as an experimental ligand in protein crystallography studies.[3][9] The compound is structurally related to inhibitors of farnesyltransferase enzymes but does not have an established clinical use or approved indication.[1][3][5]
- Other names
- (5S,18R,19S)-31‑oxo‑20‑oxa‑261113-tetraazahexacyclo[19.6.2.1,.1,.0,.0]-decosine derivative[2]CNP0514568.1[4]
02
Targets
FTase (Protein Farnesyltransferase)
Beyond the preview
Go deeper on (20S)-19,20,22,23-tetrahydro-19-oxo-5H,21H-18,20-ethano-12,14-etheno-6,10-methenobenz[d]imidazo[4,3-l][1,6,9,13]oxatriazacyclonoadedecosine-9-carbonitrile.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (20S)-19,20,22,23-tetrahydro-19-oxo-5H,21H-18,20-ethano-12,14-etheno-6,10-methenobenz[d]imidazo[4,3-l][1,6,9,13]oxatriazacyclonoadedecosine-9-carbonitrile.